Clinicopathological and prognostic significance of PD-L1 in oral cancer: A preliminary retrospective immunohistochemistry study

Oral Dis. 2021 Mar;27(2):173-182. doi: 10.1111/odi.13509. Epub 2020 Jul 14.

Abstract

Objective: To evaluate the relation between PD-L1 expression in oral cavity squamous cell carcinomas and clinicopathological features as well as survival outcomes.

Methods: A retrospective immunohistochemical study was carried out on 55 archived tumours from 55 patients. Tumours were stained for PD-L1 and scored by the proportion of tumour cells with positive membranous staining. PD-L1 scores were compared to the patient's clinicopathological characteristics for any significant associations. Kaplan-Meier curves were constructed for PD-L1 positive and negative tumours to investigate any advantage to survival.

Results: Positive PD-L1 staining was found in 58% of tumours and was significantly more likely in non-smokers, non-drinkers and in tongue squamous cell carcinomas. Increased PD-L1 was also associated with increased lymphocyte infiltration as well as PD-L1 staining in lymphocytes and the epithelium adjacent to tumour invasion. No survival benefit was seen from PD-L1 expression in tumour cells.

Conclusions: PD-L1 expression is more common in non-smokers and non-drinkers, and its presence in the adjacent non-tumour epithelium suggests it may be involved in early oncogenesis.

Keywords: PD-L1; immunohistochemistry; oral cancer; prognostic; programmed death-ligand 1.

MeSH terms

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Disease-Free Survival
  • Head and Neck Neoplasms*
  • Humans
  • Immunohistochemistry
  • Kaplan-Meier Estimate
  • Mouth Neoplasms*
  • Prognosis
  • Retrospective Studies

Substances

  • B7-H1 Antigen
  • Biomarkers, Tumor